NAD+animalAnimal model2012

The electrochemical regeneration of NAD(+) revisited.

Biotechnology and bioengineering

confidence

Key findings

Electrochemical regeneration of NAD+ achieved 99.97% yield (3000 cycles), deactivation time-dependent, not cycle-dependent; suitable for biotech.

View source on PubMed (PMID 18581294) ↗

Sample size: N/A
Population: N/A (electrochemical study)
Dosing: N/A
Duration: N/A
Route: electrochemical
Blinding: not_reported
Controls: none
Drug class: coenzyme

Full abstract

An actual yield of 99.97% (i.e., 3000 potential regenerating cycles) has been obtained for the electrochemical regeneration of NAD(+). The deactivation of the coenzyme is not related to the number of cycles; it is only time dependent. For biotechnological applications, these results show that electrochemical regeneration can compete with enzymatic regeneration for selective oxidation by dehydrogenases.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.